Europe’s medicines question: one-bloc negotiation or country-by-country bargaining?
The European Parliament has begun a critical debate over whether Brussels should consolidate its purchasing power for essential medicines or allow Member States to continue negotiating independently with major pharmaceutical suppliers, a decision that could reshape how 450 million Europeans access vital treatments. Karin Karlsbro, the lead negotiator for the centrist Renew Europe group, opened…
